Global Pirfenidone Drugs Market Growth 2026-2032

February 2026 | 105 pages | ID: G3F6B50DEF50EN
LP Information

Abstracts

The global Pirfenidone Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Pirfenidone is an antifibrotic drug used primarily in the treatment of idiopathic pulmonary fibrosis(IPF),a progressive and debilitating lung disease characterized by scarring of lung tissue.It works by inhibiting the synthesis of transforming growth factor-beta(TGF-?),andpirfenidone exerts anti-inflammatory effects by suppressing the release of pro-inflammatory mediators and inhibiting the expression of genes associated with inflammation.

United States market for Pirfenidone Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Pirfenidone Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Pirfenidone Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Pirfenidone Drugs players cover Roche, Accord Healthcare, Amneal Pharmaceuticals, Sandoz, ScieGen Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Pirfenidone Drugs Industry Forecast” looks at past sales and reviews total world Pirfenidone Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Pirfenidone Drugs sales for 2026 through 2032. With Pirfenidone Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pirfenidone Drugs industry.

This Insight Report provides a comprehensive analysis of the global Pirfenidone Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pirfenidone Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pirfenidone Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pirfenidone Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pirfenidone Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Pirfenidone Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Capsules
• Tablets

Segmentation by Application:

• Hospital and Clinic
• Retail Pharmacies
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Roche
• Accord Healthcare
• Amneal Pharmaceuticals
• Sandoz
• ScieGen Pharmaceuticals
• Gyre Pharmaceuticals
• Apotex
• Teva
• Kawin

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pirfenidone Drugs market?

What factors are driving Pirfenidone Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pirfenidone Drugs market opportunities vary by end market size?

How does Pirfenidone Drugs break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pirfenidone Drugs Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Pirfenidone Drugs by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Pirfenidone Drugs by Country/Region, 2021, 2025 & 2032
2.2 Pirfenidone Drugs Segment by Type
  2.2.1 Capsules
  2.2.2 Tablets
  2.2.3 Pirfenidone Drugs Sales by Type
    2.2.3.1 Global Pirfenidone Drugs Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Pirfenidone Drugs Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Pirfenidone Drugs Sale Price by Type (2021-2026)
2.3 Pirfenidone Drugs Segment by Application
  2.3.1 Hospital and Clinic
  2.3.2 Retail Pharmacies
  2.3.3 Other
  2.3.4 Pirfenidone Drugs Sales by Application
    2.3.4.1 Global Pirfenidone Drugs Sale Market Share by Application (2021-2026)
    2.3.4.2 Global Pirfenidone Drugs Revenue and Market Share by Application (2021-2026)
    2.3.4.3 Global Pirfenidone Drugs Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Pirfenidone Drugs Breakdown Data by Company
  3.1.1 Global Pirfenidone Drugs Annual Sales by Company (2021-2026)
  3.1.2 Global Pirfenidone Drugs Sales Market Share by Company (2021-2026)
3.2 Global Pirfenidone Drugs Annual Revenue by Company (2021-2026)
  3.2.1 Global Pirfenidone Drugs Revenue by Company (2021-2026)
  3.2.2 Global Pirfenidone Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Pirfenidone Drugs Sale Price by Company
3.4 Key Manufacturers Pirfenidone Drugs Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Pirfenidone Drugs Product Location Distribution
  3.4.2 Players Pirfenidone Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR PIRFENIDONE DRUGS BY GEOGRAPHIC REGION

4.1 World Historic Pirfenidone Drugs Market Size by Geographic Region (2021-2026)
  4.1.1 Global Pirfenidone Drugs Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Pirfenidone Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pirfenidone Drugs Market Size by Country/Region (2021-2026)
  4.2.1 Global Pirfenidone Drugs Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Pirfenidone Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pirfenidone Drugs Sales Growth
4.4 APAC Pirfenidone Drugs Sales Growth
4.5 Europe Pirfenidone Drugs Sales Growth
4.6 Middle East & Africa Pirfenidone Drugs Sales Growth

5 AMERICAS

5.1 Americas Pirfenidone Drugs Sales by Country
  5.1.1 Americas Pirfenidone Drugs Sales by Country (2021-2026)
  5.1.2 Americas Pirfenidone Drugs Revenue by Country (2021-2026)
5.2 Americas Pirfenidone Drugs Sales by Type (2021-2026)
5.3 Americas Pirfenidone Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Pirfenidone Drugs Sales by Region
  6.1.1 APAC Pirfenidone Drugs Sales by Region (2021-2026)
  6.1.2 APAC Pirfenidone Drugs Revenue by Region (2021-2026)
6.2 APAC Pirfenidone Drugs Sales by Type (2021-2026)
6.3 APAC Pirfenidone Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Pirfenidone Drugs by Country
  7.1.1 Europe Pirfenidone Drugs Sales by Country (2021-2026)
  7.1.2 Europe Pirfenidone Drugs Revenue by Country (2021-2026)
7.2 Europe Pirfenidone Drugs Sales by Type (2021-2026)
7.3 Europe Pirfenidone Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pirfenidone Drugs by Country
  8.1.1 Middle East & Africa Pirfenidone Drugs Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Pirfenidone Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Pirfenidone Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Pirfenidone Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pirfenidone Drugs
10.3 Manufacturing Process Analysis of Pirfenidone Drugs
10.4 Industry Chain Structure of Pirfenidone Drugs

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Pirfenidone Drugs Distributors
11.3 Pirfenidone Drugs Customer

12 WORLD FORECAST REVIEW FOR PIRFENIDONE DRUGS BY GEOGRAPHIC REGION

12.1 Global Pirfenidone Drugs Market Size Forecast by Region
  12.1.1 Global Pirfenidone Drugs Forecast by Region (2027-2032)
  12.1.2 Global Pirfenidone Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pirfenidone Drugs Forecast by Type (2027-2032)
12.7 Global Pirfenidone Drugs Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Roche
  13.1.1 Roche Company Information
  13.1.2 Roche Pirfenidone Drugs Product Portfolios and Specifications
  13.1.3 Roche Pirfenidone Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Roche Main Business Overview
  13.1.5 Roche Latest Developments
13.2 Accord Healthcare
  13.2.1 Accord Healthcare Company Information
  13.2.2 Accord Healthcare Pirfenidone Drugs Product Portfolios and Specifications
  13.2.3 Accord Healthcare Pirfenidone Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Accord Healthcare Main Business Overview
  13.2.5 Accord Healthcare Latest Developments
13.3 Amneal Pharmaceuticals
  13.3.1 Amneal Pharmaceuticals Company Information
  13.3.2 Amneal Pharmaceuticals Pirfenidone Drugs Product Portfolios and Specifications
  13.3.3 Amneal Pharmaceuticals Pirfenidone Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Amneal Pharmaceuticals Main Business Overview
  13.3.5 Amneal Pharmaceuticals Latest Developments
13.4 Sandoz
  13.4.1 Sandoz Company Information
  13.4.2 Sandoz Pirfenidone Drugs Product Portfolios and Specifications
  13.4.3 Sandoz Pirfenidone Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Sandoz Main Business Overview
  13.4.5 Sandoz Latest Developments
13.5 ScieGen Pharmaceuticals
  13.5.1 ScieGen Pharmaceuticals Company Information
  13.5.2 ScieGen Pharmaceuticals Pirfenidone Drugs Product Portfolios and Specifications
  13.5.3 ScieGen Pharmaceuticals Pirfenidone Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 ScieGen Pharmaceuticals Main Business Overview
  13.5.5 ScieGen Pharmaceuticals Latest Developments
13.6 Gyre Pharmaceuticals
  13.6.1 Gyre Pharmaceuticals Company Information
  13.6.2 Gyre Pharmaceuticals Pirfenidone Drugs Product Portfolios and Specifications
  13.6.3 Gyre Pharmaceuticals Pirfenidone Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Gyre Pharmaceuticals Main Business Overview
  13.6.5 Gyre Pharmaceuticals Latest Developments
13.7 Apotex
  13.7.1 Apotex Company Information
  13.7.2 Apotex Pirfenidone Drugs Product Portfolios and Specifications
  13.7.3 Apotex Pirfenidone Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Apotex Main Business Overview
  13.7.5 Apotex Latest Developments
13.8 Teva
  13.8.1 Teva Company Information
  13.8.2 Teva Pirfenidone Drugs Product Portfolios and Specifications
  13.8.3 Teva Pirfenidone Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Teva Main Business Overview
  13.8.5 Teva Latest Developments
13.9 Kawin
  13.9.1 Kawin Company Information
  13.9.2 Kawin Pirfenidone Drugs Product Portfolios and Specifications
  13.9.3 Kawin Pirfenidone Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Kawin Main Business Overview
  13.9.5 Kawin Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Pirfenidone Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pirfenidone Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Capsules
Table 4. Major Players ofTablets
Table 5. Global Pirfenidone Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global Pirfenidone Drugs Sales Market Share by Type (2021-2026)
Table 7. Global Pirfenidone Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global Pirfenidone Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global Pirfenidone Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Pirfenidone Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global Pirfenidone Drugs Sale Market Share by Application (2021-2026)
Table 12. Global Pirfenidone Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global Pirfenidone Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global Pirfenidone Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Pirfenidone Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global Pirfenidone Drugs Sales Market Share by Company (2021-2026)
Table 17. Global Pirfenidone Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Pirfenidone Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global Pirfenidone Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Pirfenidone Drugs Producing Area Distribution and Sales Area
Table 21. Players Pirfenidone Drugs Products Offered
Table 22. Pirfenidone Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Pirfenidone Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Pirfenidone Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global Pirfenidone Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Pirfenidone Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Pirfenidone Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Pirfenidone Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global Pirfenidone Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Pirfenidone Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Pirfenidone Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas Pirfenidone Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas Pirfenidone Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Pirfenidone Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas Pirfenidone Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC Pirfenidone Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC Pirfenidone Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC Pirfenidone Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Pirfenidone Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC Pirfenidone Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe Pirfenidone Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe Pirfenidone Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Pirfenidone Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe Pirfenidone Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Pirfenidone Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Pirfenidone Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Pirfenidone Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Pirfenidone Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Pirfenidone Drugs
Table 52. Key Market Challenges & Risks of Pirfenidone Drugs
Table 53. Key Industry Trends of Pirfenidone Drugs
Table 54. Pirfenidone Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Pirfenidone Drugs Distributors List
Table 57. Pirfenidone Drugs Customer List
Table 58. Global Pirfenidone Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Pirfenidone Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Pirfenidone Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Pirfenidone Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Pirfenidone Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Pirfenidone Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Pirfenidone Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Pirfenidone Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Pirfenidone Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Pirfenidone Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Pirfenidone Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Pirfenidone Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Pirfenidone Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Pirfenidone Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Roche Basic Information, Pirfenidone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Roche Pirfenidone Drugs Product Portfolios and Specifications
Table 74. Roche Pirfenidone Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Roche Main Business
Table 76. Roche Latest Developments
Table 77. Accord Healthcare Basic Information, Pirfenidone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Accord Healthcare Pirfenidone Drugs Product Portfolios and Specifications
Table 79. Accord Healthcare Pirfenidone Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Accord Healthcare Main Business
Table 81. Accord Healthcare Latest Developments
Table 82. Amneal Pharmaceuticals Basic Information, Pirfenidone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Amneal Pharmaceuticals Pirfenidone Drugs Product Portfolios and Specifications
Table 84. Amneal Pharmaceuticals Pirfenidone Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Amneal Pharmaceuticals Main Business
Table 86. Amneal Pharmaceuticals Latest Developments
Table 87. Sandoz Basic Information, Pirfenidone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Sandoz Pirfenidone Drugs Product Portfolios and Specifications
Table 89. Sandoz Pirfenidone Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Sandoz Main Business
Table 91. Sandoz Latest Developments
Table 92. ScieGen Pharmaceuticals Basic Information, Pirfenidone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. ScieGen Pharmaceuticals Pirfenidone Drugs Product Portfolios and Specifications
Table 94. ScieGen Pharmaceuticals Pirfenidone Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. ScieGen Pharmaceuticals Main Business
Table 96. ScieGen Pharmaceuticals Latest Developments
Table 97. Gyre Pharmaceuticals Basic Information, Pirfenidone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Gyre Pharmaceuticals Pirfenidone Drugs Product Portfolios and Specifications
Table 99. Gyre Pharmaceuticals Pirfenidone Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Gyre Pharmaceuticals Main Business
Table 101. Gyre Pharmaceuticals Latest Developments
Table 102. Apotex Basic Information, Pirfenidone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Apotex Pirfenidone Drugs Product Portfolios and Specifications
Table 104. Apotex Pirfenidone Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Apotex Main Business
Table 106. Apotex Latest Developments
Table 107. Teva Basic Information, Pirfenidone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Teva Pirfenidone Drugs Product Portfolios and Specifications
Table 109. Teva Pirfenidone Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Teva Main Business
Table 111. Teva Latest Developments
Table 112. Kawin Basic Information, Pirfenidone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Kawin Pirfenidone Drugs Product Portfolios and Specifications
Table 114. Kawin Pirfenidone Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Kawin Main Business
Table 116. Kawin Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Pirfenidone Drugs
Figure 2. Pirfenidone Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pirfenidone Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Pirfenidone Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pirfenidone Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pirfenidone Drugs Sales Market Share by Country/Region (2025)
Figure 10. Pirfenidone Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Capsules
Figure 12. Product Picture ofTablets
Figure 13. Global Pirfenidone Drugs Sales Market Share by Type in 2026
Figure 14. Global Pirfenidone Drugs Revenue Market Share by Type (2021-2026)
Figure 15. Pirfenidone Drugs Consumed in Hospital and Clinic
Figure 16. Global Pirfenidone Drugs Market: Hospital and Clinic (2021-2026) & (K Units)
Figure 17. Pirfenidone Drugs Consumed in Retail Pharmacies
Figure 18. Global Pirfenidone Drugs Market: Retail Pharmacies (2021-2026) & (K Units)
Figure 19. Pirfenidone Drugs Consumed in Other
Figure 20. Global Pirfenidone Drugs Market: Other (2021-2026) & (K Units)
Figure 21. Global Pirfenidone Drugs Sale Market Share by Application (2025)
Figure 22. Global Pirfenidone Drugs Revenue Market Share by Application in 2026
Figure 23. Pirfenidone Drugs Sales by Company in 2026 (K Units)
Figure 24. Global Pirfenidone Drugs Sales Market Share by Company in 2026
Figure 25. Pirfenidone Drugs Revenue by Company in 2026 ($ millions)
Figure 26. Global Pirfenidone Drugs Revenue Market Share by Company in 2026
Figure 27. Global Pirfenidone Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Pirfenidone Drugs Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Pirfenidone Drugs Sales 2021-2026 (K Units)
Figure 30. Americas Pirfenidone Drugs Revenue 2021-2026 ($ millions)
Figure 31. APAC Pirfenidone Drugs Sales 2021-2026 (K Units)
Figure 32. APAC Pirfenidone Drugs Revenue 2021-2026 ($ millions)
Figure 33. Europe Pirfenidone Drugs Sales 2021-2026 (K Units)
Figure 34. Europe Pirfenidone Drugs Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Pirfenidone Drugs Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Pirfenidone Drugs Revenue 2021-2026 ($ millions)
Figure 37. Americas Pirfenidone Drugs Sales Market Share by Country in 2026
Figure 38. Americas Pirfenidone Drugs Revenue Market Share by Country (2021-2026)
Figure 39. Americas Pirfenidone Drugs Sales Market Share by Type (2021-2026)
Figure 40. Americas Pirfenidone Drugs Sales Market Share by Application (2021-2026)
Figure 41. United States Pirfenidone Drugs Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Pirfenidone Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Pirfenidone Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Pirfenidone Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Pirfenidone Drugs Sales Market Share by Region in 2026
Figure 46. APAC Pirfenidone Drugs Revenue Market Share by Region (2021-2026)
Figure 47. APAC Pirfenidone Drugs Sales Market Share by Type (2021-2026)
Figure 48. APAC Pirfenidone Drugs Sales Market Share by Application (2021-2026)
Figure 49. China Pirfenidone Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Pirfenidone Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Pirfenidone Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Pirfenidone Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. India Pirfenidone Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Pirfenidone Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Pirfenidone Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Pirfenidone Drugs Sales Market Share by Country in 2026
Figure 57. Europe Pirfenidone Drugs Revenue Market Share by Country (2021-2026)
Figure 58. Europe Pirfenidone Drugs Sales Market Share by Type (2021-2026)
Figure 59. Europe Pirfenidone Drugs Sales Market Share by Application (2021-2026)
Figure 60. Germany Pirfenidone Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. France Pirfenidone Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Pirfenidone Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Pirfenidone Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Pirfenidone Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Pirfenidone Drugs Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Pirfenidone Drugs Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Pirfenidone Drugs Sales Market Share by Application (2021-2026)
Figure 68. Egypt Pirfenidone Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Pirfenidone Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Pirfenidone Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Pirfenidone Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Pirfenidone Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Pirfenidone Drugs in 2026
Figure 74. Manufacturing Process Analysis of Pirfenidone Drugs
Figure 75. Industry Chain Structure of Pirfenidone Drugs
Figure 76. Channels of Distribution
Figure 77. Global Pirfenidone Drugs Sales Market Forecast by Region (2027-2032)
Figure 78. Global Pirfenidone Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Pirfenidone Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Pirfenidone Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Pirfenidone Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Pirfenidone Drugs Revenue Market Share Forecast by Application (2027-2032)